# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875045-17-000024
Filing Date
2017-07-25
Accepted
2017-07-25 16:22:11
Documents
115
Period of Report
2017-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | biib-2017630x10q.htm | 10-Q | 1824985
2 | EXHIBIT 10.2 | biib-2017630xexhibit102.htm | EX-10.2 | 23096
3 | EXHIBIT 10.3 | biib-2017630xexhibit103.htm | EX-10.3 | 23472
4 | EXHIBIT 10.4 | biib-2017630xexhibit104.htm | EX-10.4 | 24519
5 | EXHIBIT 10.5 | biib-2017630xexhibit105.htm | EX-10.5 | 24709
6 | EXHIBIT 31.1 | biib-2017630xex311.htm | EX-31.1 | 14188
7 | EXHIBIT 31.2 | biib-2017630xex312.htm | EX-31.2 | 15648
8 | EXHIBIT 32.1 | biib-2017630xex321.htm | EX-32.1 | 10808
15 |  | biib-2017630acquirediprd.jpg | GRAPHIC | 21449
16 |  | biib-2017630amortization.jpg | GRAPHIC | 23257
17 |  | biib-2017630anticd20.jpg | GRAPHIC | 52337
18 |  | biib-2017630biosimilars.jpg | GRAPHIC | 25504
19 |  | biib-2017630collaborationps.jpg | GRAPHIC | 23689
20 |  | biib-2017630cos.jpg | GRAPHIC | 34435
21 |  | biib-2017630highlights.jpg | GRAPHIC | 37366
22 |  | biib-2017630incometax.jpg | GRAPHIC | 33403
23 |  | biib-2017630interferon.jpg | GRAPHIC | 38242
24 |  | biib-2017630oie.jpg | GRAPHIC | 24192
25 |  | biib-2017630otherrevenues.jpg | GRAPHIC | 33925
26 |  | biib-2017630rd.jpg | GRAPHIC | 77556
27 |  | biib-2017630rdpie2016.jpg | GRAPHIC | 36733
28 |  | biib-2017630rdpie2017.jpg | GRAPHIC | 36926
29 |  | biib-2017630reserves.jpg | GRAPHIC | 38973
30 |  | biib-2017630sga.jpg | GRAPHIC | 24035
31 |  | biib-2017630spinraza.jpg | GRAPHIC | 28949
32 |  | biib-2017630tecfidera.jpg | GRAPHIC | 40312
33 |  | biib-2017630tysabri.jpg | GRAPHIC | 38825
34 |  | biib-2017630zinbryta.jpg | GRAPHIC | 23489
35 |  | biogenlogostandarda05.jpg | GRAPHIC | 756402
| Complete submission text file | 0000875045-17-000024.txt |  | 11651676

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE DOCUMENT | biib-20170630.xml | EX-101.INS | 2399912
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | biib-20170630.xsd | EX-101.SCH | 58552
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | biib-20170630_cal.xml | EX-101.CAL | 99008
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | biib-20170630_def.xml | EX-101.DEF | 289308
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | biib-20170630_lab.xml | EX-101.LAB | 788436
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | biib-20170630_pre.xml | EX-101.PRE | 467340

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 17980644
SIC: 2836 Biological Products, (No Diagnostic Substances)